isolate
CD138+ cells from patient ID BOSTON_005 who participated in the BOSTON study and recieved selinexor + bortezomib + dexamethasone
biomaterial_provider
Parekh Lab, Icahn School of Medicine at Mount Sinai
age
62
sex
male
tissue
bone marrow
cell_type
CD138+
disease
multiple myeloma
disease_stage
I
treatment
selinexor + bortezomib + dexamethasone
RIN
9
batch
Shipment.001
RNA.Library.Prep.Method
Smart-Seq V4 Ultra Low Input Nextera XT
PFS_Days
362
PFS_Censor
1
Best_Response
CR
BioSampleModel
Human